Recent Finacing
Recent Raise
Eleven Biotherapeutics engineers fit-for-purpose protein therapeutics with its AMP-Rx platform, developing candidates like EBI-005, an interleukin-1 receptor antagonist for topical ophthalmic delivery.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors